KH
KH6.DU NewAmsterdam Pharma Co NV
- EUR
- Market cap
- -
- P/E
- -
- P/B
- 3.83x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is KH6.DU undervalued?
Graham numberThe Graham number of NewAmsterdam Pharma Co NV cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NewAmsterdam Pharma Co NV fundamental analysis
No fundamental analysis for NewAmsterdam Pharma Co NV yet.
NewAmsterdam Pharma Co NV stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of NewAmsterdam Pharma Co NV are not available yet.
NewAmsterdam Pharma Co NV dividends
NewAmsterdam Pharma Co NV has not paid dividends in the last 1 fiscal years.
Who owns NewAmsterdam Pharma Co NV
Ownership data of NewAmsterdam Pharma Co NV is not available yet.
NewAmsterdam Pharma Co NV company profile
- Company name
- NewAmsterdam Pharma Co NV
- Ticker
- KH6.DU
- Exchange
- Dusseldorf Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Address
- Website
- -